Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Current market commentary with Dr. Daniel Koller, Head Investment Management Team BB Biotech at Bellevue Asset Management.

«Cancer medicine improves the chances of a cure»

Current market commentary with Dr. Daniel Koller, Head Investment Management Team BB Biotech at Bellevue Asset Management.
09.12.2021 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993